A 5-gene panel (VAX1, CFTR, KCNV1, PROX1, and TAL1) had an 88.7% sensitivity and an 87.3% specificity for the diagnosis of bladder cancer. The gene discussed is PROX1; the disease is urinary bladder carcinoma.